...
首页> 外文期刊>BMJ Open >Predictors of hospitalisations for heart failure and mortality in patients with pulmonary hypertension associated with left heart disease: a systematic review
【24h】

Predictors of hospitalisations for heart failure and mortality in patients with pulmonary hypertension associated with left heart disease: a systematic review

机译:左心病相关性肺动脉高压患者心衰和死亡率的住院预测:系统评价

获取原文
           

摘要

Objectives Left heart disease (LHD) is the main cause of pulmonary hypertension (PH), but little is known regarding the predictors of adverse outcome of PH associated with LHD (PH-LHD). We conducted a systematic review to investigate the predictors of hospitalisations for heart failure and mortality in patients with PH-LHD. Design Systematic review. Data sources PubMed MEDLINE and SCOPUS from inception to August 2013 were searched, and citations identified via the ISI Web of Science. Study selection Studies that reported on hospitalisation and/or mortality in patients with PH-LHD were included if the age of participants was greater than 18?years and PH was diagnosed using Doppler echocardiography and/or right heart catheterisation. Two reviewers independently selected studies, assessed their quality and extracted relevant data. Results In all, 45 studies (38 from Europe and USA) were included among which 71.1% were of high quality. 39 studies were published between 2003 and 2013. The number of participants across studies ranged from 46 to 2385; the proportion of men from 21% to 91%; mean/median age from 63 to 82?years; and prevalence of PH from 7% to 83.3%. PH was consistently associated with increased mortality risk in all forms of LHD, except for aortic valve disease where findings were inconsistent. Six of the nine studies with data available on hospitalisations reported a significant adverse effect of PH on hospitalisation risk. Other predictors of adverse outcome were very broad and heterogeneous including right ventricular dysfunction, functional class, left ventricular function and presence of kidney disease. Conclusions PH is almost invariably associated with increased mortality risk in patients with LHD. However, effects on hospitalisation risk are yet to be fully characterised; while available evidence on the adverse effects of PH have been derived essentially from Caucasians.
机译:目的左心病(LHD)是肺动脉高压(PH)的主要原因,但对于与LHD(PH-LHD)相关的PH不良结果的预测因素知之甚少。我们进行了系统的审查,以调查PH-LHD患者心衰和死亡率的住院预测因素。设计系统审查。搜索从开始到2013年8月的PubMed MEDLINE和SCOPUS数据源,并通过ISI Web of Science识别引文。研究选择如果参与者的年龄大于18岁并且使用多普勒超声心动图和/或右心导管检查诊断为PH,则应包括报道PH-LHD患者住院和/或死亡的研究。两名评价者独立选择研究,评估其质量并提取相关数据。结果共纳入45项研究(欧洲和美国38项),其中71.1%为高质量。 2003年至2013年间发表了39项研究。研究的参与者人数从46到2385不等。男性比例从21%升至91%;平均/中位年龄从63岁到82岁; PH的患病率从7%上升到83.3%。在所有形式的LHD中,PH一直与死亡风险增加相关,但主动脉瓣疾病除外,其结果不一致。九项具有住院数据的研究中有六项报告了PH对住院风险的重大不利影响。不良结局的其他预测因素非常广泛且异质,包括右心室功能障碍,功能类别,左心室功能和肾脏疾病的存在。结论PH几乎总是与LHD患者死亡风险增加相关。然而,对住院风险的影响尚待充分表征。尽管有关PH不利影响的现有证据主要来自高加索人。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号